Field Trip Health Ltd.
FTRP · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | -0.00 | -0.00 | 0.00 |
| FCF Yield | -432.14% | -38.96% | -4.40% |
| EV / EBITDA | 0.47 | -0.82 | -22.13 |
| Quality | |||
| ROIC | -56.94% | -15.72% | -27.38% |
| Gross Margin | -88.27% | -60.67% | -840.30% |
| Cash Conversion Ratio | 0.81 | 0.71 | 0.73 |
| Growth | |||
| Revenue 3-Year CAGR | 1,593.86% | 986,691.30% | 99,900.00% |
| Free Cash Flow Growth | -152.91% | -589.04% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | 0.69 | 1.45 | 3.27 |
| Interest Coverage | -48.90 | -62.74 | -145.16 |
| Efficiency | |||
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 92.28 | -429.90 | 63,646.06 |